Xconomy Forum: Robo Madness West
- Science & Technology
- SRI International, Menlo Park CA
It’s no secret that biotech is feeling it once again. Stocks are way up, and startups are seizing the opportunity to sail through a wide-open IPO window. That bull market isn’t just generating big returns for investors, it’s helping fuel the next round of innovation. Ambitious startups are sprouting up, sparked by science that is turning heads. New, nontraditional sources of cash are turning their attention to life sciences, creating unlikely options for fledgling biotechs that simply weren’t imagined a short time ago. But which ideas are generating the most buzz? What’s it going to take for the grandiose visions to become reality? And what does it all mean for drug discovery and health? Join Xconomy as we bring together some of the Boston biotech scene’s top innovators, venture capitalists, and executives, who are at the forefront of some of the biggest new ideas in life sciences.
Michael Bonney, CEO, Cubist Pharmaceuticals
Douglas Williams, EVP, Research and Development, Biogen Idec
John Maraganore, CEO, Alnylam Pharmaceuticals
Rob Armstrong, former VP, Global External Research and Development, Eli Lilly
David Berry, CEO, Seres Health; Partner, Flagship Ventures
Kevin Bitterman, Interim CEO, Editas Medicine; Partner, Polaris Partners
Katrine Bosley, Entrepreneur-in-residence, The Broad Institute
Richard Brudnick, VP, Business Development, Biogen Idec
Jason Rhodes, President and CFO, Epizyme
Nancy Simonian, CEO, Syros Pharmaceuticals
Roger Stein, Chief Analytics Officer, State Street Global Exchange
Robert Urban, Head, J&J Innovation Center, Boston
Feng Zhang, Professor of Biomedical Engineering, MIT
Registration: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
View full agenda
Tickets are transferable but not refundable.
To inquire about press registration, e-mail email@example.com.
Alexandria Real Estate Equities
Capital Royalty • Cubist Pharmaceuticals • Genentech
Halloran Consulting Group • Kauffman Foundation • Kilpatrick Townsend
Latham & Watkins • Nelsen Biomedical • Rice University
Texas Medical Center • University of Houston
VENTURE CAPITAL MEMBERS
Advanced Technology Ventures • ARCH Venture Partners • Avalon Ventures
Boston Millennia Partners • Fairhaven Capital • Flagship Ventures
North Bridge Venture Partners • Polaris Partners • SR One • Third Rock Ventures
LIFE SCIENCE MEMBERS
Alnylam Pharmaceuticals • Infinity Pharmaceuticals
Moderna Therapeutics • Sarepta Therapeutics
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.